For 15 years, PHARMAGATE has been helping pharmaceutical companies navigate regulatory pathways across the EURASIA region, supporting market access through deep local expertise.
As part of our interview series with regional experts, we continue exploring the regulatory landscape of key pharmaceutical markets across the region.
This time, we focus on Uzbekistan – one of Central Asia's fastest-growing pharmaceutical markets. Recent regulatory reforms, greater alignment with international standards, and evolving compliance requirements are creating both new opportunities and new challenges for pharmaceutical companies.
In this interview, our experts discuss:
- Recent regulatory developments and Uzbekhistan market trends
- Key considerations for registration and lifecycle management
- Common challenges for international manufacturers
- Practical recommendations for successful market access to Uzbekhistan
